Miss Adrienne Brooke Allman, SLP | |
102 Smithfield St, Buckhannon, WV 26201-2620 | |
(304) 624-6554 | |
(304) 624-5223 |
Full Name | Miss Adrienne Brooke Allman |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 102 Smithfield St, Buckhannon, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811142029 | NPI | - | NPPES |
3810013769 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miss Adrienne Brooke Allman, SLP 102 Smithfield St, Buckhannon, WV 26201-2620 Ph: (304) 624-6554 | Miss Adrienne Brooke Allman, SLP 102 Smithfield St, Buckhannon, WV 26201-2620 Ph: (304) 624-6554 |
News Archive
As previously announced, RaySearch Laboratories AB has been contacted by a US company named Prowess, which claims that RaySearch has infringed on a US patent in respect of which Prowess has a license.
A team of researchers from the US and Belgium applied a structure-based approach with early monitoring of cathepsin L inhibition along with SARS-CoV-2 3CLpro inhibition. They identified a potent and selective SARS-CoV-2 3CLpro inhibitor, ALG-097111, which has proven activity against SARS-CoV-2 in SARS-CoV-2 hamster models in vivo. This study is published in the journal, Biochemical and Biophysical Research Communications.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announced that the first-time-in-man Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated and dosing has begun.
QRxPharma Limited announced today, as part of its Phase 3 program, the initiation of a registration (also called pivotal) trial (Study 008) comparing efficacy and safety profiles of MoxDuo(TM)IR against component doses of morphine and oxycodone alone for the management of moderate to severe post-operative pain following bunionectomy surgery. The Company expects to complete dosing by close of Q2 2010.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
› Verified 5 days ago
Nancy H Crossett, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Smithfield St, Buckhannon, WV 26201 Phone: 304-624-6554 Fax: 304-624-5223 | |
Michael Mendicino, MS,SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Smithfield St, Buckhannon, WV 26201 Phone: 304-624-6554 Fax: 304-624-5223 | |
Connie H Everett, MS,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Smithfield St, Buckhannon, WV 26201 Phone: 304-624-6554 Fax: 304-624-5223 | |
Emily Ross, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Smithfield St, Buckhannon, WV 26201 Phone: 304-624-6554 Fax: 304-624-5223 | |
Mrs. Elizabeth Ann H Mcclain, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Smithfield St, Buckhannon, WV 26201 Phone: 304-624-6554 Fax: 304-624-5223 | |
Tamara Neal Smithson, MA ED CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Smithfield St, Buckhannon, WV 26201 Phone: 304-624-6554 Fax: 304-624-5223 | |
Andrea Louise Ellis, MS,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Smithfield St, Buckhannon, WV 26201 Phone: 304-624-6554 Fax: 304-624-5223 |